merck is widely tipped to come out on top with it's results tomorrow re nsclc at ACA....
interesting to us is the mooted trial in the US for keytruda and efti alpha in a
supply collaboration with Immutep......presumably merck had discussions with
Immutep about which direction to proceed in these collaborations.....
- Forums
- ASX - By Stock
- IMM
- upcoming events
IMM
immutep limited
Add to My Watchlist
1.00%
!
5.0¢
upcoming events, page-3
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.